Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,7818 USD | +4,24 % | -0,26 % | -12,06 % |
05/04 | ACHILLES THERAPEUTICS PLC : Recibe una recomendación de compra del Chardan Research | ZM |
05/04 | ACHILLES THERAPEUTICS PLC : Piper Sandler es ahora neutral | ZM |
Resumen de negocios
Número de empleados: 210
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Sergio Quezada
FOU | Founder | 49 | 01/11/20 |
Karl Peggs
FOU | Founder | 57 | 01/11/20 |
Iraj Ali
CEO | Chief Executive Officer | 48 | 01/01/18 |
Robert Coutts
DFI | Director of Finance/CFO | 40 | 01/11/20 |
Edward Samuel
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/22 |
Shree Patel
COO | Chief Operating Officer | - | - |
James Taylor
PRN | Corporate Officer/Principal | - | 01/07/22 |
Tariq Ahmed
HRO | Human Resources Officer | - | 01/03/20 |
Daniel Hood
LAW | General Counsel | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Carsten Boess
BRD | Director/Board Member | 57 | 01/04/20 |
Edwin Moses
CHM | Chairman | 69 | - |
Director/Board Member | 69 | 04/05/22 | |
Michael Giordano
BRD | Director/Board Member | 66 | 01/09/18 |
Julie O'Neill
BRD | Director/Board Member | 58 | 03/05/21 |
Iraj Ali
CEO | Chief Executive Officer | 48 | 01/01/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 41 082 948 | 38 326 282 ( 93,29 %) | 0 | 93,29 % |
Información de la empresa
Achilles Therapeutics Plc
245 Hammersmith Road
W6 8PW, London
+44 20 8154 4600
http://www.achillestx.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-12,06 % | 32,12 M | |
+12,08 % | 42,68 mil M | |
+0,67 % | 42,4 mil M | |
+47,07 % | 40,04 mil M | |
-6,20 % | 28,31 mil M | |
+6,55 % | 24,94 mil M | |
-21,66 % | 18,96 mil M | |
+29,96 % | 12,3 mil M | |
-1,57 % | 11,95 mil M | |
-4,80 % | 11,55 mil M |
- Bolsa de valores
- Acciones
- Acción ACHL
- Empresa Achilles Therapeutics plc